Coronavirus Vaccine Maker Pfizer Posts a Mixed Q4

Pfizer (NYSE:PFE), now famous as the co-developer of the coronavirus vaccine BNT162b2, released its final quarterly results for fiscal 2020 on Tuesday.

These show that the company earned $11.68 billion in revenue, which was 12% higher than the same quarter of 2019. Of that, BNT162b2 -- which received emergency use authorization from the FDA in December -- was responsible for $154 million.